Intestinal Cell News Volume 9.06 | Feb 17 2023

    0
    18








    2023-02-17 | ICN 9.06


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.06 – 17 February, 2023
    TOP STORY

    Multilevel Proteomic Analyses Reveal Molecular Diversity between Diffuse-Type and Intestinal-Type Gastric Cancer

    Researchers carried out multilevel proteomic analyses, including proteome, phospho-proteome, and transcription factor activity profiles, of 196 cases covering diffuse-type gastric cancer and intestinal-type gastric cancer in Chinese patients.
    [Nature Communications]

    Full Article
    Virtual Conference Exhibition: Pluripotent Stem Cells
    PUBLICATIONSRanked by the impact factor of the journal

    Long-Term Platinum-Based Drug Accumulation in Cancer-Associated Fibroblasts Promotes Colorectal Cancer Progression and Resistance to Therapy

    Scientists applied elemental imaging to the mapping of chemotherapy (CT) biodistribution after therapy in residual colorectal cancer and achieved a comprehensive analysis of the genetic program induced by oxaliplatin-based CT in the tumor microenvironment.
    [Nature Communications]

    Full Article

    ERdj5 Protects Goblet Cells from Endoplasmic Reticulum Stress-Mediated Apoptosis under Inflammatory Conditions

    The authors used ERdj5-knockout mice to investigate the potential roles of ERdj5 in IBD. ERdj5 deficiency caused severe inflammation in mouse colitis models and weakened gut barrier function by increasing NF-κB-mediated inflammation.
    [Experimental & Molecular Medicine]

    Full Article

    Litchi Procyanidins Inhibit Colon Cancer Proliferation and Metastasis by Triggering Gut-Lung Axis Immunotherapy

    Litchi procyanidins significantly inhibited CT26 colon cancer cells proliferation and metastasis in vivo and in vitro. LPC significantly inhibited CT26 colon cancer cells metastasis through increasing CD8+ cytotoxic T lymphocytes infiltration and decreasing the number of macrophages.
    [Cell Death & Disease]

    Full Article

    Epithelial Gab1 Calibrates RIPK3-Dependent Necroptosis to Prevent Intestinal Inflammation

    Scientists reported that Gab1 expression was decreased in patients with IBD and inversely correlated with IBD severity.
    [JCI Insight]

    AbstractGraphical Abstract

    ATG16L1 Protects from IFN-γ-Induced Cell Death in the Small Intestinal Crypt

    Researchers examined the role of Atg16l1 in protecting the murine small intestinal epithelium from T cell-mediated damage using the anti-CD3 model of enteropathy.
    [Mucosal Immunology]

    Full Article

    LncRNA-NEF Suppressed Oxaliplatin Resistance and Epithelial-Mesenchymal Transition in Colorectal Cancer through Epigenetically Inactivating MEK/ERK Signaling

    An oxaliplatin-resistant colorectal cancer cell line was established and lncRNA-Neighboring Enhancer of FOXA2 (NEF) was down-regulated in this resistant cell line.
    [Cancer Gene Therapy]

    Abstract

    Crosstalk between Protein Kinase C α and Transforming Growth Factor β Signaling Mediated by Runx2 in Intestinal Epithelial Cells

    Scientists identified a novel crosstalk between protein kinase C α (PKCα) and transforming growth factor β (TGFβ) signaling. RNA-Seq analysis of non-transformed intestinal crypt-like cells and colorectal cancer cells identified TGFβ receptor 1 as a target of PKCα signaling.
    [Journal of Biological Chemistry]

    Full Article

    Slc11a1 Gene Polymorphism Influences Dextran Sulfate Sodium (DSS)-Induced Colitis in a Murine Model of Acute Inflammation

    Researchers investigated the possible modulating effect of the Slc11a1 R and S variants in DSS-induced colitis by using low acute inflammatory responses (AIRmin) mice homozygous for Slc11a1 R (AIRminRR) or S (AIRminSS) alleles.
    [Genes And Immunity]

    Full Article
    Five tips for returning to the lab after time off
    REVIEWS

    The Huge Potential of Targeting Copper Status in the Treatment of Colorectal Cancer

    The authors summarize the mechanisms by which altered copper status causes colorectal cancer (CRC) progression and emphasize the potential of regulating copper status in treating CRC.
    [Clinical and Translational Oncology]

    Abstract
    INDUSTRY AND POLICY NEWS

    US FDA Advisory Committee Votes in Support of Trials Designed to Evaluate Jemperli (Dostarlimab-Gxly) as a Potential Treatment for Mismatch Repair-Deficient/Microsatellite Instability-High Locally Advanced Rectal Cancer

    The US FDA voted in support of the question of whether data from two proposed single-arm trials will be “sufficient to characterize the benefits and risks” of Jemperli in the curative-intent setting for patients with mismatch repair-deficient/microsatellite instability-high locally advanced rectal cancer.
    [GSK plc]

    Press Release
    FEATURED EVENT

    ESMO Targeted Anticancer Therapies Congress 2023

    March 6 – 8, 2023
    Paris, France

    > See All Events

    JOB OPPORTUNITIES

    PhD Student – Gut Microbiome of IBD

    Luxembourg Institute of Health – Esch-sur-Alzette, Luxembourg

    Program Leader – Basic Science

    Vanderbilt-Ingram Cancer Center – Nashville, Tennessee, United States

    Postdoctoral Research Fellow – Cancer Stem Cells

    Virginia Commonwealth University – Richmond, Virginia, United States

    Staff Scientist – Genetics and Epigenetics of Gastrointestinal Cancers

    Beckman Research Institute – Monrovia, California, United States

    Research Associate – Oncogenic Signaling

    Imperial College London – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter